Eli Lilly leads the weight loss market ahead of Novo Nordisk. Eli Lilly also has a more diversified lineup of products than its peer. Even considering its seemingly more reasonable valuation, Novo ...

Jan 12 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of blockbuster GLP-1 drugs, underscoring how cheaper, ...

Novo Nordisk launched an oral version of its best-selling weight management medicine. It may not help catch up to Eli Lilly, whose oral anti-obesity drug is also expected to hit the market soon. Novo ...

Novo Nordisk’s (NYSE: NVO) Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable 2x story moving forward, provided it effectively ...

Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our website policy prior to making financial decisions. Novo Nordisk A/S (NVO) shares ...

A daily pill for weight loss has officially arrived in the U.S. On Monday, Novo Nordisk rolled out the first GLP-1 weight-loss pill, an oral version of Wegovy. The company says the new option is ...

A pill form of weight-loss drug Wegovy, manufactured by Danish drugmaker Novo Nordisk, is now available in the U.S., giving Americans access to an oral medication to treat obesity. The starting dose ...

Danish drugmaker Novo Nordisk is launching its once-daily Wegovy pill in the United States on Monday, offering 1.5 milligram and 4 mg doses at $149 per month for self-paying patients in an intensely ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Jan. 5 (UPI) --Pharmaceutical company Novo Nordisk announced Monday that a new pill-version of its GLP-1 weight-loss drug is now "broadly available" at U.S. pharmacies. The Wegovy pill, available in ...

Novo Nordisk’s NOVO.B1.17%increase; green up pointing triangle Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish ...

LONDON, Jan 5 (Reuters) - Britain's medicines regulator said on Monday it was reviewing Novo Nordisk's (NOVOb.CO), opens new tab application for an oral 25 milligram version of its weight-loss drug ...